Regulatory T cells in primary sjögren disease: regulatory mechanisms and therapeutic prospects

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

• Level A · Stronger Clinical Evidence
• Level B · Emerging clinical evidence with positive signals
• Level C · Early human research exploring benefits
• Level D · Scientific groundwork from lab and animal studies
• Emerging · Emerging topic under active research

Abstract (original English)

Primary Sjögren disease (SjD) is a chronic inflammatory autoimmune disorder characterized by lymphocyte proliferation and progressive damage to exocrine glands. Its pathogenesis is complex, and clinical treatment remains challenging. Regulatory T cells (Tregs), a subset of inhibitory T lymphocytes, play a pivotal role in maintaining peripheral immune tolerance and immune homeostasis. They are also critically involved in the pathogenesis and progression of various autoimmune diseases, including SjD. Consequently, modulating the proliferation, activation, and functional balance of Tregs holds significant promise for ameliorating the immune-inflammatory microenvironment in SjD and slowing disease progression. Recent studies have shown that mesenchymal stem cells (MSCs), fenofibrate, and metformin can promote Treg proliferation and improve their function, thereby restoring the Th17/Treg immune balance. These interventions synergistically reduce inflammatory responses, downregulate abnormal immune activation, and alleviate tissue pathological damage, ultimately leading to significantly increased saliva and tear secretion. This review summarizes the regulatory mechanisms of Tregs in SjD based on recent literature and explores the potential of Treg-targeted therapeutic strategies for SjD, aiming to provide a theoretical basis for the development of novel treatment approaches for this

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.